ADMA Biologics Inc. (ADMA)
16.39
0.22 (1.36%)
At close: Jan 29, 2025, 3:59 PM
16.33
-0.34%
After-hours Jan 29, 2025, 07:29 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| PE Ratio | -35.85 | -9.01 | -2.33 | -1.92 | -3.81 | -1.64 | -1.68 | -3.19 | -4.68 | -6.17 | -3.28 | -6.17 | -807.82 | -1.04K | -1.07 | -0.86 | -0.72 |
| PS Ratio | 3.92 | 4.98 | 2.43 | 3.98 | 7.41 | 6.36 | 3.23 | 5.84 | 11.71 | 17.55 | 16.61 | 40.27 | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 7.49 | 5.05 | 1.39 | 1.90 | 8.30 | 5.46 | 1.82 | -13.96 | 102.35 | 17.27 | 2.36 | 4.78 | -16.37K | -61.78K | -7.58 | -1.61 | 4.67 |
| P/FCF Ratio | 265.09 | -10.46 | -1.56 | -1.46 | -2.72 | -1.67 | -1.84 | -3.39 | -5.44 | -6.1 | -4.6 | -6.41 | -737.07 | -1.09K | -0.87 | -1.12 | -0.91 |
| P/OCF Ratio | 115.04 | -12.9 | -1.75 | -1.65 | -2.85 | -1.72 | -1.97 | -3.41 | -5.45 | -7.06 | -4.68 | -6.52 | -737.07 | -1.09K | -0.87 | -1.12 | -0.91 |
| OCF/S Ratio | 0.03 | -0.39 | -1.39 | -2.42 | -2.6 | -3.69 | -1.64 | -1.71 | -2.15 | -2.49 | -3.55 | -6.17 | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 1.05 | 1.02 | 0.73 | 1.11 | 3.23 | 2.24 | 1.07 | -4.55 | 19.16 | 2.49 | 0.24 | 0.42 | -7.52K | -20.81K | -4.08 | -1.2 | 2.20 |
| Quick Ratio | 1.69 | 2.73 | 2.77 | 3.62 | 2.34 | 2.69 | 5.35 | 1.48 | 4.23 | 5.33 | 8.03 | 6.98 | 0.87 | -274.15 | 0.75 | 0.17 | 1.45 |
| Current Ratio | 5.16 | 6.89 | 6.87 | 7.71 | 6.12 | 4.63 | 6.69 | 1.93 | 5.05 | 5.74 | 8.49 | 7.68 | 0.87 | 0.97 | 0.75 | 0.17 | 1.45 |
| Asset Turnover | 0.78 | 0.44 | 0.29 | 0.20 | 0.23 | 0.19 | 0.21 | 0.45 | 0.30 | 0.22 | 0.10 | 0.07 | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | 0.86 | -2.04 | -4.47 | -5.42 | -4.61 | -10.92 | -11.96 | -7.74 | -8.42 | -12.45 | -24.33 | -257.77 | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.21 | -0.56 | -0.6 | -0.99 | -2.18 | -3.33 | -1.08 | 4.38 | -21.89 | -2.8 | -0.72 | -0.77 | 20.26 | 59.32 | 7.10 | 1.87 | -6.48 |
| Return on Assets (ROA) | -0.09 | -0.24 | -0.31 | -0.42 | -0.45 | -0.74 | -0.41 | -0.82 | -0.76 | -0.62 | -0.49 | -0.47 | -3.11 | -1.71 | -2.3 | -9.4 | -2.03 |
| Return on Capital (ROIC) | 0.08 | -0.13 | -0.24 | -0.35 | -0.37 | -0.76 | -0.4 | -1.39 | -0.8 | -0.7 | -0.53 | -0.58 | 20.26 | 59.34 | 7.10 | 1.87 | -6.48 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.09 | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.53 | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 34.44% | 22.89% | 1.45% | -45.17% | -34.6% | -148.42% | -28.14% | 40.34% | 39.93% | 36.74% | 34.04% | 40.16% | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -10.94% | -55.29% | -104.34% | -207.5% | -194.37% | -387.06% | -192.26% | -183.05% | -250.36% | -284.22% | -506.17% | -653% | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -10.94% | -42.77% | -88.52% | -179.41% | -164.5% | -387.06% | -192.26% | -183.05% | -250.36% | -293.55% | -506.17% | -708.24% | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | 8.38% | -25.55% | -72.12% | -153.75% | -141.14% | -354.95% | -172.71% | -162.56% | -216.14% | -270.79% | -490.37% | -707.36% | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | 1.48% | -47.65% | -155.52% | -271.74% | -272.6% | -381.36% | -175.51% | -172.05% | -215.18% | -287.85% | -361.32% | -628.08% | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | 1.98% | -25.78% | -65.89% | -141.69% | -122.76% | -334.26% | -172.71% | -157.64% | -218.14% | -267.61% | -479.15% | -689.21% | n/a | n/a | n/a | n/a | n/a |